Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

Inclusion Criteria: * Korean men and women aged 20 to 85 years with coronary heart disease (CHD) or CHD equivalent patients * Atherosclerotic plaques in coronary computed tomography (CT) or angiography or * History of PCI or coronary artery bypass graft surgery (CABG) \> one year or * Diabetes mellitus (including type I and type II) or * Confirmed carotid atherosclerotic plaque with sonography, CT or angiography or * History of peripheral artery disease or * History of cerebrovascular disease Exclusion Criteria: * Patients who had history of PCI within one year * Patients who used concomitant anticoagulants * Patients who had hypersensitivity to aspirin or clopidogrel, serious bleeding tendency, history of intracranial hemorrhage, sign of active bleeding, uncontrolled hypertension * Chronic alcoholism or drug addiction * Women who were pregnant or breastfeeding or who were not using an effective method of contraception * The use of glycoprotein IIb/IIIa inhibitor, daily NSAIDs, lipid lowering agent (except atorvastatin), or substances with possible interactions with the study drug